{"id":959842,"date":"2026-05-07T09:06:58","date_gmt":"2026-05-07T13:06:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/"},"modified":"2026-05-07T09:06:58","modified_gmt":"2026-05-07T13:06:58","slug":"qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/","title":{"rendered":"QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations"},"content":{"rendered":"

\nQiagen’s CFO projected 6% full-year QuantiFERON growth on February 5, 2026. Actual Q1 2026 volumes declined and the company is now projecting sales to remain steady at $500 million
\n<\/h2>\n
\n

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) — Qiagen (NASDAQ: QGEN) investors lost approximately 10% of their share value after the company slashed FY 2026 sales-growth guidance from “at least 5% CER” to just 1-2% CER and cut adjusted diluted EPS guidance to at least $2.43 from a prior floor of $2.50 CER. Shareholders who lost money on QGEN are encouraged to\u00a0submit their information to discuss their legal rights<\/u><\/a>. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com<\/u><\/a> or by telephone at (212) 363-7500.<\/p>\n

On February 5, 2026, CFO Roland Sackers told investors on the Q4 2025 earnings call: “We expect QuantiFERON to grow at a low single-digit CER rate in the first quarter of 2026 \u2026 a normalized full-year run-rate for \u201826 of about 6% CER growth.” On the same call, CEO Thierry Bernard stated: “We are on track to achieve our ’28 goal for at least $2 billion in combined sales from these products.” Weeks later, actual Q1 2026 QuantiFERON test volumes showed a 5% CER decline year-over-year. The company then cut full-year sales-growth guidance to 1-2% CER and lowered adjusted diluted EPS to at least $2.43.<\/p>\n

The gap between what management projected and what materialized was stark. The \u201clow single-digit CER rate\u201d growth projection for QuantiFERON in Q1 became a 5% decline. The “at least 5% CER” company-wide sales growth outlook was reduced to 1-2% CER. The adjusted EPS floor dropped from $2.50 to $2.43. Levi & Korsinsky is investigating whether Qiagen’s officers possessed information about weakening QuantiFERON demand at the time these projections were made.<\/p>\n

If you purchased Qiagen shares and suffered a loss, click here to discuss your legal rights with Levi & Korsinsky<\/a>. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com<\/u><\/a> or by telephone at (212) 363-7500.<\/p>\n

ABOUT THE FIRM — For over two decades, Levi & Korsinsky has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years.<\/p>\n

Frequently Asked Questions About the QGEN Investigation<\/p>\n

\n Q: How much did QGEN stock drop?<\/strong> A: Shares fell more than 10%. From a closing price of $38.09 on April 27, 2026, QGEN stock closed at $34.02 on April 28, 2026, a $4.07 drop.<\/p>\n

\n Q: What specific misstatements are being investigated?<\/strong> A: The QGEN investigation concerns statements made by the company and its management regarding its sales-growth outlook, QuantiFERON TB test demand, its debt classification, and the adequacy of its non-GAAP financial disclosures during the class period. When the true state was revealed, the stock price declined sharply.<\/p>\n

\n Q: What do QGEN investors need to do right now?<\/strong> A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at jlevi@levikorsinsky.com<\/u><\/a> or (212) 363-7500. No immediate action is required to remain eligible as a class member in any potential suit.<\/p>\n

\n Q: What if I already sold my QGEN shares — can I still recover losses?<\/strong> A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the determined class period and sold at a loss may still participate.<\/p>\n

\n Q: What does it cost me to participate?<\/strong> A: Nothing. Securities investigations and the potential resultant class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.<\/p>\n

\n Q: Do I need to go to court or give testimony?<\/strong> A: No. This is currently just an investigation. Even if a suit is filed, however, the overwhelming majority of class members never appear in court or give depositions. You submit a claim form to receive your portion of recovery.<\/p>\n

\n Q: Has Levi & Korsinsky handled similar cases before?<\/strong> A: Yes, including securities class actions involving revenue inflation, earnings guidance fraud, dividend misrepresentation, and executive misconduct across numerous industries.<\/p>\n

CONTACT:<\/p>\n

Levi & Korsinsky, LLP<\/p>\n

Joseph E. Levi, Esq.<\/p>\n

Ed Korsinsky, Esq.<\/p>\n

33 Whitehall Street, 27th Floor<\/p>\n

New York, NY 10004<\/p>\n

\n
\n jlevi@levikorsinsky.com<\/u>
\n <\/a>\n <\/p>\n

Tel: (212) 363-7500<\/p>\n

Fax: (212) 363-7171<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Qiagen’s CFO projected 6% full-year QuantiFERON growth on February 5, 2026. Actual Q1 2026 volumes declined and the company is now projecting sales to remain steady at $500 million NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) — Qiagen (NASDAQ: QGEN) investors lost approximately 10% of their share value after the company slashed FY 2026 sales-growth guidance from “at least 5% CER” to just 1-2% CER and cut adjusted diluted EPS guidance to at least $2.43 from a prior floor of $2.50 CER. Shareholders who lost money on QGEN are encouraged to\u00a0submit their information to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. On February 5, 2026, … <\/p>\n

Continue reading “QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-959842","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nQGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Qiagen’s CFO projected 6% full-year QuantiFERON growth on February 5, 2026. Actual Q1 2026 volumes declined and the company is now projecting sales to remain steady at $500 million NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) — Qiagen (NASDAQ: QGEN) investors lost approximately 10% of their share value after the company slashed FY 2026 sales-growth guidance from “at least 5% CER” to just 1-2% CER and cut adjusted diluted EPS guidance to at least $2.43 from a prior floor of $2.50 CER. Shareholders who lost money on QGEN are encouraged to\u00a0submit their information to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. On February 5, 2026, … Continue reading "QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-07T13:06:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTA4MiM3NTg4NjcxIzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations\",\"datePublished\":\"2026-05-07T13:06:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/\"},\"wordCount\":669,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNTA4MiM3NTg4NjcxIzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/\",\"name\":\"QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNTA4MiM3NTg4NjcxIzIwMjA0MjY=\",\"datePublished\":\"2026-05-07T13:06:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNTA4MiM3NTg4NjcxIzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNTA4MiM3NTg4NjcxIzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/","og_locale":"en_US","og_type":"article","og_title":"QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations - Market Newsdesk","og_description":"Qiagen’s CFO projected 6% full-year QuantiFERON growth on February 5, 2026. Actual Q1 2026 volumes declined and the company is now projecting sales to remain steady at $500 million NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) — Qiagen (NASDAQ: QGEN) investors lost approximately 10% of their share value after the company slashed FY 2026 sales-growth guidance from “at least 5% CER” to just 1-2% CER and cut adjusted diluted EPS guidance to at least $2.43 from a prior floor of $2.50 CER. Shareholders who lost money on QGEN are encouraged to\u00a0submit their information to discuss their legal rights. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. On February 5, 2026, … Continue reading \"QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-07T13:06:58+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTA4MiM3NTg4NjcxIzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations","datePublished":"2026-05-07T13:06:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/"},"wordCount":669,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTA4MiM3NTg4NjcxIzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/","name":"QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTA4MiM3NTg4NjcxIzIwMjA0MjY=","datePublished":"2026-05-07T13:06:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTA4MiM3NTg4NjcxIzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTA4MiM3NTg4NjcxIzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qgen-shareholder-investigation-levi-korsinsky-investigates-qiagen-for-possible-securities-law-violations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/959842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=959842"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/959842\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=959842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=959842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=959842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}